Traws Pharma

(NASDAQ) TRAW

Current Price$1.37

Market Cap$20.77M

Since IPO (2013)-100%

5 Year-99%

1 Year-7%

1 Month-19%

Traws Pharma Financials at a Glance

Market Cap

$20.77M

Revenue (TTM)

$2.79M

Net Income (TTM)

-$23.94M

EPS (TTM)

-$2.27

P/E Ratio

-0.60

Dividend

$0.00

Beta (Volatility)

1.12 (Average)

Dividend

$0.00

Beta (Volatility)

1.12 (Average)

Price

$1.37

Volume

Open

$1.45

Price

$1.37

Volume

Open

$1.45

Previous Close

$1.37

Daily Range

$1.33 - $1.46

52-Week Range

$1.00 - $3.27

Estimated Earnings Date

Aug 6, 2026

Dividend

$0.00

Beta (Volatility)

1.12 (Average)

Price

$1.37

Volume

Open

$1.45

Previous Close

$1.37

Daily Range

$1.33 - $1.46

52-Week Range

$1.00 - $3.27

Estimated Earnings Date

Aug 6, 2026

TRAW News

Why Jabil Circuit, Inc., Onconova Therapeutics Inc., and Gogo Inc. Plunged Today

Dan CaplingerDec 18, 2013

Why Onconova Therapeutics Inc. Shares Crashed

Sean WilliamsDec 18, 2013

Keep an Eye on Onconova, Enzymotec, DepoMed, and Omeros Today

Leo SunDec 18, 2013

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Traws Pharma

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Iain David Dukes, PhD

Website

www.trawspharma.com

Headquarters

Newtown, PA 18940, US

TRAW Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-5639%

Return on Capital

Return on Assets

-2%

Earnings Yield

-1.67%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$20.77M

Shares Outstanding

15.16M

Volume

Avg. Volume

2.16M

Financials (TTM)

Gross Profit

$2.79M

Operating Income

-$17.88M

EBITDA

-$17.81M

Operating Cash Flow

-$18.19M

Capital Expenditure

-$2.59M

Free Cash Flow

-$20.77M

Cash & ST Invst.

$3.82M

Total Debt

$0.00

Traws Pharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$20.77M

N/A

Market Cap/Employee

$3.46M

N/A

Employees

N/A

Net Income

-$7.11M

-42.6%

EBITDA

-$6.90M

-32.5%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Net Cash

$3.13M

-81.4%

Accounts Receivable

$1.69M

+9272.2%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-1.78%

N/A

Return on Invested Capital

2.83%

N/A

Free Cash Flow

-$2.58B

-26047.0%

Operating Cash Flow

-$2.58B

-26047.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

SNSESensei Biotherapeutics, Inc.

SNSESensei Biotherapeutics, Inc.$14.65-11.75%

CINGCingulate Inc.

CINGCingulate Inc.$4.50-6.35%

COCPCocrystal Pharma, Inc.

COCPCocrystal Pharma, Inc.$0.96-8.16%

BOLTBolt Biotherapeutics, Inc.

BOLTBolt Biotherapeutics, Inc.$4.56-3.80%

IMRNImmuron Limited

IMRNImmuron Limited$1.25-1.57%

EVGNEvogene Ltd.

EVGNEvogene Ltd.$0.62+1.53%

IMNNImunon, Inc.

IMNNImunon, Inc.$2.06-1.90%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

KEELKeel Infrastructure

KEELKeel Infrastructure$5.13-0.13%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.50+0.02%

QQQInvesco QQQ Trust

QQQInvesco QQQ Trust$705.06-0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.72-0.13%

ONDSOndas

ONDSOndas$10.43-0.13%

TAT&T

TAT&T$22.75-0.00%

POETPoet Technologies

POETPoet Technologies$11.86-0.23%

Questions About TRAW

What is the current price of Traws Pharma?

Traws Pharma is trading at $1.37 per share.

What is the 52-week range for Traws Pharma?

Over the past 52 weeks, Traws Pharma has traded between $1.00 and $3.27.

How much debt does Traws Pharma have?

As of the most recent reporting period, Traws Pharma reported total debt of $0.00.

How much cash does Traws Pharma have on hand?

Traws Pharma reported $3.13M in cash and cash equivalents in its most recent financial results.

What is Traws Pharma’s dividend yield?

Traws Pharma does not currently have a dividend yield.

Traws Pharma

Traws Pharma Financials at a Glance

TRAW News

Traws Pharma Posts Q2 Revenue Jump

Why Onconova Therapeutics Stock Soared Today

This Week in Biotech: Buyouts, an FDA Approval, and Clinical Data. Oh, My!

3 Horrendous Health-Care Stocks This Week

Why Onconova Therapeutics Inc. Shares Imploded

Why Jabil Circuit, Inc., Onconova Therapeutics Inc., and Gogo Inc. Plunged Today

Why Onconova Therapeutics Inc. Shares Crashed

Keep an Eye on Onconova, Enzymotec, DepoMed, and Omeros Today

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Traws Pharma

TRAW Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Traws Pharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About TRAW

What is the current price of Traws Pharma?

What is the 52-week range for Traws Pharma?

How much debt does Traws Pharma have?

How much cash does Traws Pharma have on hand?

What is Traws Pharma’s dividend yield?

Premium Investing Services